FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914409938> ?p ?o ?g. }

• W2914409938 endingPage "26" @default.
• W2914409938 startingPage "19" @default.
• W2914409938 abstract "The development of new blood vessels is directly related to the occurrence of eye diseases. Anti-angiogenic drugs can theoretically be extended to the treatment of ophthalmic diseases. In this study, axitinib, a class of tyrosine kinase inhibitors, was loaded via the amphiphilic copolymer MPEG-PCL, improving its dispersibility in water. Axitinib-loaded micelles showed low toxicity in concentration gradient assays. Additionally, multiple doses by scratch assay confirmed that axitinib had no significant effect on normal cell migration, and biosafety test results showed good cell compatibility. After we established the corneal neovascularization model after an alkali burn in rats, the anti-angiogenic efficacy was tested, with dexamethasone as a positive control. The results showed that axitinib-loaded micelles had anti-angiogenic effects without obvious tissue toxicity. As a class of targeted tyrosine kinase inhibitors, axitinib can be used in the treatment of ocular neovascular diseases through nanocrystallization." @default.
• W2914409938 created "2019-02-21" @default.
• W2914409938 creator A5022499603 @default.
• W2914409938 creator A5028472046 @default.
• W2914409938 creator A5042970405 @default.
• W2914409938 creator A5046859830 @default.
• W2914409938 creator A5049232069 @default.
• W2914409938 creator A5062617219 @default.
• W2914409938 creator A5085174800 @default.
• W2914409938 date "2019-04-01" @default.
• W2914409938 modified "2023-10-14" @default.
• W2914409938 title "Micelle-solubilized axitinib for ocular administration in anti-neovascularization" @default.
• W2914409938 cites W1504910494 @default.
• W2914409938 cites W176812056 @default.
• W2914409938 cites W1959357132 @default.
• W2914409938 cites W1976918086 @default.
• W2914409938 cites W1979828325 @default.
• W2914409938 cites W1999240903 @default.
• W2914409938 cites W2016740531 @default.
• W2914409938 cites W2018457789 @default.
• W2914409938 cites W2027226047 @default.
• W2914409938 cites W2037962223 @default.
• W2914409938 cites W2038451782 @default.
• W2914409938 cites W2042492722 @default.
• W2914409938 cites W2048729493 @default.
• W2914409938 cites W2060076017 @default.
• W2914409938 cites W2106695112 @default.
• W2914409938 cites W2120718661 @default.
• W2914409938 cites W2130256619 @default.
• W2914409938 cites W2136843236 @default.
• W2914409938 cites W2137437106 @default.
• W2914409938 cites W2143326104 @default.
• W2914409938 cites W2143734566 @default.
• W2914409938 cites W2152072770 @default.
• W2914409938 cites W2309208903 @default.
• W2914409938 cites W2473480037 @default.
• W2914409938 cites W2509725694 @default.
• W2914409938 cites W2550936658 @default.
• W2914409938 cites W2727700849 @default.
• W2914409938 cites W2734976548 @default.
• W2914409938 cites W2736973656 @default.
• W2914409938 cites W2808490717 @default.
• W2914409938 cites W2809751127 @default.
• W2914409938 cites W2810797337 @default.
• W2914409938 doi "https://doi.org/10.1016/j.ijpharm.2019.01.051" @default.
• W2914409938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30710659" @default.
• W2914409938 hasPublicationYear "2019" @default.
• W2914409938 type Work @default.
• W2914409938 sameAs 2914409938 @default.
• W2914409938 citedByCount "29" @default.
• W2914409938 countsByYear W29144099382019 @default.
• W2914409938 countsByYear W29144099382020 @default.
• W2914409938 countsByYear W29144099382021 @default.
• W2914409938 countsByYear W29144099382022 @default.
• W2914409938 countsByYear W29144099382023 @default.
• W2914409938 crossrefType "journal-article" @default.
• W2914409938 hasAuthorship W2914409938A5022499603 @default.
• W2914409938 hasAuthorship W2914409938A5028472046 @default.
• W2914409938 hasAuthorship W2914409938A5042970405 @default.
• W2914409938 hasAuthorship W2914409938A5046859830 @default.
• W2914409938 hasAuthorship W2914409938A5049232069 @default.
• W2914409938 hasAuthorship W2914409938A5062617219 @default.
• W2914409938 hasAuthorship W2914409938A5085174800 @default.
• W2914409938 hasConcept C11268172 @default.
• W2914409938 hasConcept C126322002 @default.
• W2914409938 hasConcept C147789679 @default.
• W2914409938 hasConcept C178790620 @default.
• W2914409938 hasConcept C184651966 @default.
• W2914409938 hasConcept C185592680 @default.
• W2914409938 hasConcept C2776539811 @default.
• W2914409938 hasConcept C2778019345 @default.
• W2914409938 hasConcept C2778271429 @default.
• W2914409938 hasConcept C2778695046 @default.
• W2914409938 hasConcept C2780394083 @default.
• W2914409938 hasConcept C2780401358 @default.
• W2914409938 hasConcept C29730261 @default.
• W2914409938 hasConcept C502942594 @default.
• W2914409938 hasConcept C71924100 @default.
• W2914409938 hasConcept C98274493 @default.
• W2914409938 hasConceptScore W2914409938C11268172 @default.
• W2914409938 hasConceptScore W2914409938C126322002 @default.
• W2914409938 hasConceptScore W2914409938C147789679 @default.
• W2914409938 hasConceptScore W2914409938C178790620 @default.
• W2914409938 hasConceptScore W2914409938C184651966 @default.
• W2914409938 hasConceptScore W2914409938C185592680 @default.
• W2914409938 hasConceptScore W2914409938C2776539811 @default.
• W2914409938 hasConceptScore W2914409938C2778019345 @default.
• W2914409938 hasConceptScore W2914409938C2778271429 @default.
• W2914409938 hasConceptScore W2914409938C2778695046 @default.
• W2914409938 hasConceptScore W2914409938C2780394083 @default.
• W2914409938 hasConceptScore W2914409938C2780401358 @default.
• W2914409938 hasConceptScore W2914409938C29730261 @default.
• W2914409938 hasConceptScore W2914409938C502942594 @default.
• W2914409938 hasConceptScore W2914409938C71924100 @default.
• W2914409938 hasConceptScore W2914409938C98274493 @default.
• W2914409938 hasFunder F4320321001 @default.
• W2914409938 hasLocation W29144099381 @default.
• W2914409938 hasLocation W29144099382 @default.

• next